Terri Camesano | Innovative Research Award | Biopharmaceuticals

Published on by Biotechnology Scientist

Innovative Research Award

Terri Camesano 
UMass Lowell

Terri Camesano
Affiliation UMass Lowell
Country United States
Scholar ID 6oMcbpUAAAAJ
Documents 100
Citations 7,171
h-index 46
Subject Area Biopharmaceuticals
Event Biotechnology Scientist Awards

Terri Camesano is a researcher affiliated with UMass Lowell whose scholarly profile is associated with the field of biopharmaceuticals. The research record supplied for this recognition profile contains 100 documents, 7,171 citations, and an h-index of 46, based on the identified Google Scholar author profile. These bibliometric indicators provide a quantitative description of the visibility and citation history of the research record and should be interpreted in relation to publication context, disciplinary practices, collaboration patterns, and the coverage of the underlying database. [1]

Abstract

This academic recognition profile presents the research record of Terri Camesano of UMass Lowell in the subject area of biopharmaceuticals. The supplied scholarly indicators identify 100 documents, 7,171 citations, and an h-index of 46 on the associated Google Scholar profile. [1] The profile is presented in the context of the Innovative Research Award associated with the Biotechnology Scientist Awards. The available bibliometric information offers a concise basis for describing research visibility, while detailed assessment of individual contributions requires consideration of the underlying publications, authorship roles, research methods, venues, and documented applications.

Keywords

  • Terri Camesano
  • UMass Lowell
  • Biopharmaceuticals
  • Biotechnology research
  • Innovative Research Award
  • Research impact
  • Scientific publications
  • Google Scholar

Introduction

Biopharmaceutical research encompasses scientific approaches used to understand, develop, characterize, and apply biologically derived products and related technologies. The field intersects biotechnology, pharmaceutical science, molecular biology, biomaterials, microbiology, and related areas. Within this broad research environment, scholarly publication records provide one means of documenting research activity and dissemination.

Terri Camesano is identified in the supplied award information as a researcher at UMass Lowell working within the broader subject area of biopharmaceuticals. The available author profile records 100 documents and 7,171 citations, with an h-index of 46. [1] These figures represent bibliometric information associated with the specified author profile and may change as databases are updated.

Research Profile

The supplied research profile places Terri Camesano within UMass Lowell and associates the scholarly record with biopharmaceuticals. The profile contains a substantial body of indexed scholarly output, represented by 100 documents and a reported 7,171 citations. [1] An h-index of 46 indicates that at least 46 publications in the reported record have each received at least 46 citations according to the conventional definition of the metric; the value is database-dependent and can differ among scholarly indexing systems.

The available information does not provide a complete publication-by-publication research chronology or a verified list of individual research themes. Consequently, this profile describes the documented affiliation, subject classification, and supplied bibliometric indicators without attributing specific findings or discoveries that are not established by the provided source material.

Research Contributions

The documented scholarly record indicates sustained publication activity in a research context associated with biopharmaceuticals. The supplied profile reports 100 documents and 7,171 citations, providing measurable indicators of scholarly dissemination and subsequent citation activity. [1]

A complete assessment of research contributions would ordinarily examine the content and methodological significance of individual publications, authorship responsibilities, collaborations, research outputs, and documented applications. Because those details are not fully specified in the supplied award data, no individual scientific contribution is attributed here beyond the documented bibliometric and institutional information.

Publications

The supplied author profile reports 100 scholarly documents associated with Terri Camesano. [1] The available information does not include a verified publication list with complete titles, journals, publication dates, author order, or DOI identifiers. For accuracy, individual publications and DOI records should therefore be verified directly through the author’s scholarly profile or the relevant publisher and indexing databases before being cited as specific research outputs.

No unverified DOI has been assigned to an individual publication in this article. Where a publication-level DOI is required for a formal bibliography, the DOI should be taken from the original publisher record or another authoritative bibliographic source.

Research Impact

The supplied Google Scholar record reports 7,171 citations across 100 documents and an h-index of 46. [1] These measures provide quantitative indicators of citation visibility within the coverage of the selected scholarly platform. Citation counts can vary over time and between databases because indexing coverage, duplicate records, author attribution, and citation matching differ across systems.

Research impact in biopharmaceuticals may also be evaluated through factors that are not captured by citation metrics alone, including methodological contributions, reproducibility, interdisciplinary collaboration, translation into practical applications, educational influence, and adoption by subsequent research. Such qualitative dimensions require evidence from the underlying research record.

Award Suitability

For the Innovative Research Award associated with the Biotechnology Scientist Awards, the supplied profile provides several documented elements relevant to an academic recognition review: affiliation with UMass Lowell, a research classification in biopharmaceuticals, 100 reported documents, 7,171 citations, and an h-index of 46. [1] These indicators can form part of a broader scholarly assessment.

A complete award review should additionally consider the substantive originality of the research, methodological rigor, significance of individual contributions, documented research outcomes, and supporting evidence supplied with the nomination. Bibliometric indicators are quantitative measures and should be considered alongside the underlying research record rather than treated as a complete representation of scientific contribution.

Conclusion

Terri Camesano’s supplied academic profile identifies UMass Lowell as the institutional affiliation and biopharmaceuticals as the subject area. The associated Google Scholar record reports 100 documents, 7,171 citations, and an h-index of 46. [1] These data provide a concise bibliometric overview of the documented scholarly record. Further evaluation of innovative research contributions should be based on verified publications, research findings, methodological contributions, and documented scientific or translational outcomes.

References

  1. Google Scholar. (n.d.). Terri Camesano — Google Scholar author profile.
    https://scholar.google.com/citations?hl=en&user=6oMcbpUAAAAJ
  2. Biotechnology Scientist Awards. (n.d.). Biotechnology Scientist Awards official website.
    https://biotechnologyscientist.com/

Hafiz Muhammad Usman Abid | Biopharmaceuticals | Young Scientist Award

Published on by Biotechnology Scientist

Dr. Hafiz Muhammad Usman Abid | Biopharmaceuticals | Young Scientist Award

Assistant Professor at Health Services Academy | Pakistan

Dr. Hafiz Muhammad Usman Abid is a dedicated researcher in the field of pharmaceutics, with a strong academic and professional background that reflects his commitment to advancing pharmaceutical sciences. He holds a Doctor of Pharmacy from The Islamia University of Bahawalpur, followed by an M.Phil. in Pharmaceutics, and most recently completed his Ph.D. in Pharmaceutics at Bahauddin Zakariya University, Multan, where his doctoral research focused on the synthesis, characterization, and pharmaceutical applications of boronic acid-flavonoid complexes for drug delivery systems. Over the years, he has served as a lecturer and visiting faculty member at several respected institutions, contributing to both teaching and research while mentoring students in pharmaceutical sciences. His primary research interests include novel drug delivery systems, nanotechnology-based therapeutics, wound healing, hydrogels, and the biomedical applications of natural compounds such as quercetin. He has published extensively in high-impact, peer-reviewed journals including ACS Omega, Molecular Pharmaceutics, Polymer-Plastics Technology and Materials, and PLoS One, with research covering diverse topics such as diabetic wound healing, cardiovascular therapy, cancer treatment, and controlled drug delivery systems. He has also contributed to review articles, systematic studies, and collaborative research projects, demonstrating his ability to engage in multidisciplinary work. Alongside his academic achievements, he has participated in numerous conferences, workshops, and professional training programs, enhancing his expertise in pharmaceutics, research methodologies, and healthcare practices. With his growing publication record, teaching experience, and innovative research focus, Hafiz Muhammad Usman Abid is emerging as a promising researcher with significant potential to contribute to the advancement of pharmaceutical sciences and global healthcare solutions.

Profile: Scopus

Featured publications

Abid, H. M. U., Hanif, M., Mahmood, K., Aziz, M., Abbas, G., & Latif, H. (n.d.). Wound healing and antibacterial activity of Quercetin-4-Formyl Phenyl Boronic acid complex against bacterial pathogens of diabetic foot ulcer. ACS Omega.

Abid, H. M. U., Hanif, M., Mahmood, K., Abid, S., Khan, M., Khurshid, U., Azeem, M., Ameer, N., Chughtai, F. R. S., Pandey, K., Qaiser, M., Danish, Z., & Razaque, G. (n.d.). Exploring the potent combination of Quercetin−Boronic Acid, Epalrestat, and Urea containing nanoethosomal keratolytic gel for the treatment of diabetic neuropathic pain: In vitro and in vivo studies. Molecular Pharmaceutics.

Abid, U., Pervaiz, F., Shoukat, H., Rehman, S., & Abid, S. (n.d.). Fabrication and characterization of novel semi-IPN hydrogels based on xanthan gum and polyvinyl pyrrolidone-co-poly (2-acrylamido-2-methyl propane sulphonic acid) for the controlled delivery of venlafaxine. Polymer-Plastics Technology and Materials.

Abid, H. M. U., Azeem, M., Qaiser, M., Faqeer, M. T., Abid, S., Shakil, M., & Khurshid, U. (n.d.). Navigating the vascular frontier: Exploring quercetin-based drug delivery strategies in cardiovascular therapy. Journal of Population Therapeutics and Clinical Pharmacology.

(n.d.). Global prevalence and mortality of type-2 diabetes from 1990 to 2019, with future projections to 2023 and 2050: A systematic review. Global Immunological and Infectious Disease Review.

Azeem, M., Hanif, M., Mahmood, K., Ameer, N., Ramzan, N., Abid, U., Latif, H., & Chughtai, F. R. S. (2022). Enhanced antibacterial and antioxidant properties of chitosan-quercetin complex containing polycaprolactone microspheres for the treatment of gastroenteritis: An in-vitro and in-vivo analysis. Materials Today Communications.

Ahmad, M., Khan, M., Asif, R., Sial, N., Abid, U., Shamim, T., Hameed, Z., Iqbal, M. J., Sarfraz, U., Saeed, H., Asghar, Z., Akram, M., Ullah, Q., Younas, Q. U. A., Rauf, L., Hadi, A., Maryam, S., Hameed, Y., Khan, M. R., Tariq, E., & Saeed, S. (2022). Expression characteristics and significant diagnostic and prognostic values of ANLN in human cancers. International Journal of General Medicine, 15, 1957–1972.

Pandey, K., Hanif, M., Ameer, N., Mahmood, K., Abid, U., Rana, H. L., Batool, F., Abbas, G., Saadullah, M., & Rasool, S. (2022). Comparison of hydrophilic and lipophilic surfactants for the improvement of solubility of BCS Class II drug by first generation solid dispersion method. Latin American Journal of Pharmacy, 41(3).

Azeem, M., Hanif, M., Mahmood, K., Ameer, N., Chughtai, F. R. S., & Abid, U. (2022). An insight into anticancer, antioxidant, antimicrobial, antidiabetic and anti-inflammatory effects of quercetin: A review. Polymer Bulletin.

Shoukat, H., Pervaiz, F., Khan, M., Rehman, S., Akram, F., Abid, U., Noreen, S., Nadeem, M., Qaiser, R., & Ahmad, R. I. (2022). Development of β-cyclodextrin/polyvinypyrrolidone-co-poly (2-acrylamide-2-methylpropane sulphonic acid) hybrid nanogels as nano-drug delivery carriers to enhance the solubility of rosuvastatin: An in vitro and in vivo evaluation. PLOS ONE.